Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Bioventus (BVS) Depreciation & Amortization (IS) (2020 - 2026)

Bioventus filings provide 6 years of Depreciation & Amortization (IS) readings, the most recent being $1.3 million for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (IS) fell 26.64% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.7 million, a 25.16% decrease, with the full-year FY2025 number at $5.7 million, down 25.16% from a year prior.
  • Depreciation & Amortization (IS) hit $1.3 million in Q4 2025 for Bioventus, down from $1.4 million in the prior quarter.
  • In the past five years, Depreciation & Amortization (IS) ranged from a high of $3.3 million in Q2 2022 to a low of $1.3 million in Q4 2025.
  • Median Depreciation & Amortization (IS) over the past 5 years was $2.0 million (2021), compared with a mean of $2.0 million.
  • The widest YoY moves for Depreciation & Amortization (IS): up 69.04% in 2022, down 43.02% in 2022.
  • Bioventus' Depreciation & Amortization (IS) stood at $2.7 million in 2021, then crashed by 43.02% to $1.5 million in 2022, then skyrocketed by 36.23% to $2.1 million in 2023, then fell by 15.89% to $1.8 million in 2024, then dropped by 26.64% to $1.3 million in 2025.
  • The last three reported values for Depreciation & Amortization (IS) were $1.3 million (Q4 2025), $1.4 million (Q3 2025), and $1.4 million (Q2 2025) per Business Quant data.